From no drugs to 3: Patients with spinal muscular atrophy now face hard choices – BioPharma Dive

Permission granted by Cheryl Yoder

Jud Broadhurst was 14 years old when he began to notice the symptoms.

Playing competitive soccer, Broadhurst would fall, seemingly “for no reason,” he said. But there was one, lurking in his genes. Broadhurst had a form of spinal muscular atrophy, a rare neuromuscular condition that was causing his muscles to weaken over time.

At the time, no medicines were available to slow the relentless march of Broadhurst’s disease. Doctors said he would be in a wheelchair by age 20, a prediction he swore to defy with a lifetime of healthy eating and exercise.

Click here to read full article

Font Resize